sonar-pro
Targets an average marketing authorization (MA) approval timeline of six months or less for pharmaceutical products.
{
  "id": "ccbae5b7-9651-4aa7-9a31-ad6efa1b5a5e",
  "choices": [
    {
      "finish_reason": "stop",
      "index": 0,
      "logprobs": null,
      "message": {
        "content": "{\"status\":\"NO\",\"explanation\":\"Malaysia does not target an average marketing authorization approval timeline of six months or less; recent studies and regulatory briefings report average approval timelines for pharmaceutical products as approximately 400–515 calendar days (about 13–17 months), depending on product type and review pathway[2][5].\"}",
        "refusal": null,
        "role": "assistant",
        "annotations": null,
        "audio": null,
        "function_call": null,
        "tool_calls": null
      },
      "delta": {
        "role": "assistant",
        "content": ""
      }
    }
  ],
  "created": 1755750339,
  "model": "sonar-pro",
  "object": "chat.completion",
  "service_tier": null,
  "system_fingerprint": null,
  "usage": {
    "completion_tokens": 67,
    "prompt_tokens": 23,
    "total_tokens": 90,
    "completion_tokens_details": null,
    "prompt_tokens_details": null,
    "search_context_size": "low",
    "cost": {
      "input_tokens_cost": 0.0,
      "output_tokens_cost": 0.001,
      "request_cost": 0.006,
      "total_cost": 0.007
    }
  },
  "citations": [
    "https://www.freyrsolutions.com/what-is-the-pharmaceutical-products-approval-process-in-malaysia",
    "https://cirsci.org/wp-content/uploads/2020/05/Mohd-Sani-et-al-2020-Evaluation-of-Malaysia-regulatory-process-combined-with-correction.pdf",
    "https://gabionline.net/policies-legislation/npra-malaysia-trials-new-timelines-for-variation-applications",
    "https://japsonline.com/admin/php/uploads/4454_pdf.pdf",
    "https://cirsci.org/wp-content/uploads/2020/02/CIRS-RD-Briefing-72-Trends-in-the-regulatory-landscape-Asia.pdf"
  ],
  "search_results": [
    {
      "title": "What is the Pharmaceutical Products Approval Process in ...",
      "url": "https://www.freyrsolutions.com/what-is-the-pharmaceutical-products-approval-process-in-malaysia",
      "date": null,
      "last_updated": "2025-04-08"
    },
    {
      "title": "[PDF] An Evaluation of Malaysian Regulatory Process for New Active ...",
      "url": "https://cirsci.org/wp-content/uploads/2020/05/Mohd-Sani-et-al-2020-Evaluation-of-Malaysia-regulatory-process-combined-with-correction.pdf",
      "date": null,
      "last_updated": "2025-04-28"
    },
    {
      "title": "NPRA Malaysia trials new timelines for variation applications",
      "url": "https://gabionline.net/policies-legislation/npra-malaysia-trials-new-timelines-for-variation-applications",
      "date": "2024-11-05",
      "last_updated": "2025-07-25"
    },
    {
      "title": "[PDF] Biosimilar drug lag and evolution in Malaysia",
      "url": "https://japsonline.com/admin/php/uploads/4454_pdf.pdf",
      "date": null,
      "last_updated": "2025-05-01"
    },
    {
      "title": "RDB72 Asia trends",
      "url": "https://cirsci.org/wp-content/uploads/2020/02/CIRS-RD-Briefing-72-Trends-in-the-regulatory-landscape-Asia.pdf",
      "date": null,
      "last_updated": "2025-08-10"
    }
  ]
}